Recombinant Subunit Vaccine Development for COVID-19

Vaccines are powerful weapons against many human diseases, especially infectious diseases. In response to coronavirus infections, Creative Biostructure, with its expertise in structural biology and protein engineering, now provides comprehensive preclinical research services for the development of recombinant subunit vaccines for coronavirus infection. Recombinant Subunit Vaccine Development for COVID-19 are working to improve structure-based vaccine design and develop novel methods that can increase accessibility and reduce costs. 

https://www.creative-biostructure.com/coronavirus/recombinant-subunit-vaccine-development-services-p40.htm